Volker Hagen

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor   gene

Christoph Walz, Georgia Metzgeroth, Claudia Haferlach et al. · Haematologica · 2007 · 91 citations · Full text

Life Sciences, Genetics, Hematology +13

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer

Norbert Marschner, Stefan Zacharias, Florian Lordick et al. · JAMA Network Open · 2020 · 86 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial

M. Kaufmann, Nicolaì Maass, Serban Dan Costa et al. · European Journal of Cancer · 2010 · 38 citations

Medicine, Oncology, Pharmacology +12

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities

Günter Emons, Eric Steiner, Dirk Vordermark et al. · Geburtshilfe und Frauenheilkunde · 2018 · 36 citations · Full text

Medicine, Gynecology, Oncology +12